Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)

Inclusion Criteria: 1. age of 20-70 years; 2. diagnosed with type 2 diabetes inadequately controlled under life style intervention with 3 months before screening; 3. HbA1c ≥6.5% and ≤10.0%, and fasting plasma glucose ≥7 and ≤13.3mmol/L at baseline; 4. diagnosed with dislipidemia with triglycerides\>150mg/dL (1.70mmol/L), and/or total cholesterol \>200mg/dL (5.16mmol/L), and/or LDL-c\>100mg/dL (2.58mmol/L) 5. body mass index (BMI): 20\<BMI\<40 kg/m2; Exclusion Criteria: 1. moderate or severe liver dysfunction, abnormal renal function; 2. severe dysfunction of the heart; 3. histories of acute diabetic complications including diabetic ketoacidosis or hyperosmolar hyperglycemic non-ketotic coma within 3 months; 4. psychiatric disease or severe infection; 5. pregnancy or planned pregnancy; 6. use of any drug (including insulin) for treatment of diabetes or dyslipidemia within 3 months; 7. use of chronic (\>7 days) systemic glucocorticoid therapy within 8 weeks or receive growth hormone therapy within 6 months; 8. diagnosed with type 1 diabetes, or gestational diabetes, or other specific types of diabetes; 9. history of malignant tumor within 5 years.